share_log

三星医疗获国海证券买入评级,配用电和医疗双轮驱动,海外配电持续获得突破

JRJ Finance ·  Aug 24 16:06  · Ratings

8月24日,三星医疗获国海证券买入评级,近一个月三星医疗获得4份研报关注。研报预计2024-2026年公司有望实现营业收入144/180/214亿元,同比增速分别为+26%、+25%、+19%;归母净利润为23.8/30.0/36.1亿元,同比增速分别为+25%、+26%、+20%。研报认为,三星医疗是电表出海头部企业,配电业务不断突破。

风险提示:规模扩张的管理风险,行业政策的风险,投资风险,医疗运营风险,医疗政策风险。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment